MedPath

Dexmedetomidine in asthma

Phase 2
Recruiting
Conditions
Asthma.
Asthma
Registration Number
IRCT20131118015446N14
Lead Sponsor
Ahvaz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

All of patients whit Asthma attack
Age between 18-55 years old

Exclusion Criteria

Pregnancy
Age under 18 and more than 55 years old
Smoking more than 10 pack/year
Other chronic deaseas

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
PEFR. Timepoint: 0, 30, 60 minutes after treatmen. Method of measurement: Spirometry.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath